Sequential BCG and electromotive mitomycin versus BCG alone for high-risk superficial bladder cancer: a randomised controlled trial
Year: 2005
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Lancet Oncology
Language: English
Subfield: Surgery
Field: Medicine
Domain: Health Sciences
Keywords: superficial bladder cancer, BCG, mitomycin C, intravesical chemotherapy, immunotherapy, combination therapy, disease-free interval, recurrence, progression-free survival, maintenance therapy, high-risk superficial bladder cancer, transurethral resection, disease-specific survival, overall survival, time to progression, recurrence-free survival, disease-free survival
Open Access status: green
OpenAlex ID: W2111419267
